Role of interleukin-6 in immune complex induced models of vascular injury

Inflammation

Volumn 29, Issue 4-6, 2005, Pages 154-162

  McClintock, Shannon D ^a   Barron, Adam G ^a   Olle, Eric W ^a   Deogracias, Michael P ^a   Warner, Roscoe L ^a   Opp, Mark ^a   Johnson, Kent J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Dermal arthus; IL 6 deficient; Vascular permeability; Vasculitis

Indexed keywords

CYTOKINE; INTERLEUKIN 6; PROTEIN;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHUS PHENOMENON; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNE COMPLEX DISEASE; IMMUNOPATHOGENESIS; LUNG ALVEOLITIS; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; VASCULITIS;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ARTHUS REACTION; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; INTERLEUKIN-6; LEUKOCYTES; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERMEABILITY; PNEUMONIA; PROTEINS; PULMONARY ALVEOLI; UP-REGULATION; VASCULITIS;

EID: 33845423548     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-006-9011-1     Document Type: Article

References (35)

1. Heinrich, P. C., R. Behrmann, S. Haan, H. M. Hermanns, G. Muller-Newen, and F. Schaper. 2003. Review article. Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem. J. 15(374(Pt 1)):1-20.
2. Tackey, E., P. E. Lipsky, and G. G. Illei. 2004. Rationale for interleukine-6 blockade in systemic lupus erythematosus. Lupus. 13(5):339-343.
3. Naka, T., N. Nishimoto, and T. Kishimoto. 2002. The paradigm of IL-6: from basic science to medicine. Arthritis Res. 4(Suppl 3):S233-S242.
4. Sundy, J. S., and B. F. Haynes. 2000. Cytokines and adhesion molecules in the pathogenesis of vasculitis. Curr. Rheumatol. Rep. 2(5):402-410.
5. Chodorowska, G., and D. Czelej. 2003. Drug-induced hyperalergic vasculitis-activity of selected cytokines and acute phase proteins in plasma. Ann. Univ. Mariae Curie-Sklodowska Sect D, Med. 58(1):43-47.
6. Ohlsson, S., J. Wieslander, and M. Segelmark. 2004. Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis. Prediction of outcome? Mediat. Inflamm. 13(4):275-283.
7. Nalbant, S., B. Koc, C. Top, Y. Kucukardali, Y. Baykai, M. Danaci, and I. H. Kocer. 2002. Hypersensivity vasculitis and cytokines. Rheumatol. Int. 22(6):244-248.
8. Goronzy, J. J., and C. M. Weyand. 2002. Cytokines in giant-cell arteritis. Review. Clevel. Clin. J Med. 69(Suppl 2):S1191-S11914.
9. Muller Kobold, A. C., and C. G. Kallenberg. 1999. Monocyte activation in patients with Wegener's granulomatosis. Ann. Rheum. Dis. 58(4):237-245.
10. Tomer, Y., V. Barak, B. Bilburd, and Y. Shoenfeld. 1999. Cytokines in experimental autoimmune vasculitis. Evidence for a Th2 type response. Clin. Exp. Rheumatol. 17(5):521-526.
11. Shanley, T. P., J. L. Foreback, D. G. Remick, T. R. Ulich, S. L. Kunkel, and P. A. Ward. 1997. Regulatory effects of interleukin-6 in immunoglobulin G immune complex-induced lung injury. Am. J. Pathol. 151(1):193-203.
12. Morrow, J. D., and M. R. Opp. 2005. Diurnal variation of lipopolysaccharide-induced alterations in sleep and body temperature of interleukin-6-deficient mice. Brain Behav. Immun. 19(1):40-51.
13. Johnson, K. J., and P. A. Ward. 1974. Acute immunologic pulmonary alveolitis. J. Clin. Invest. 54(2):349-357.
14. Ward, P. A. 1965. Cochrane CG. Bound complement and immunologic injury of blood vessels. J. Exp. Med. 121:215-234.
15. Ward, P. A., J. S. Warren, and K. J. Johnson. 1988. Leukocytes, oxidants and tissue injury. Perspect. Crit. Care 1:69-81.
16. Warren, J. S., K. J. Johnson, and P. A. Ward. 1991. Immunoglobulin and complement mediated immune injury. In: The lung: scientific foundations, R. J. Crystal, J. B. West, P. J. Barnes, N. S. Cherniack and E. R. Weibel eds. Raven, New York, pp. 1939-1949.
17. Guo, R. F., and P. A. Ward. 2005. Role of C5a in inflammatory responses. Review. Ann. Rev. Immunol. 23:821-852.
18. Warner, R. L., C. S. Lewis, L. Beltran, E. M. Younkin, J. Varani, and K. J. Johnson. 2001. Role of stromelysin 1 and gelatinase B in experimental acute lung injury. Am. J. Respir. Cell Mol. Biol. 24 (5):537-544.
19. Warren, J. S. 1991. Disparate roles for TNF in the pathogenesis of acute immune complex alveolitis and dermal vasculitis. Clin. Immunol. Immunopathol. 61(2 Pt 1):249-259.
20. Speyer, C. L., N. J. Rancilio, S. D. McClintock, J. D. Crawford, H. Gao, J. V. Sarma, and P. A. Ward. 2005. Regulatory effects of estrogen on acute lung inflammation in mice. Am. J. Physiol. Cell Physiol. 288(4):C881-C890.
21. Riedemann, N. C., T. A. Neff, R. F. Guo, K. D. Bernacki, I. J. Laudes, J. V. Sarma, J. D. Lambris, and P. A. Ward. 2003. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J. Immunol. 170(1):503-507.
22. Gennari, R., and J. W. Alexander. 1995. Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependent manner by enhancing host defense. Crit. Care Med. 23(12):1945-1953.
23. Remick, D. G., G. Bolgos, S. Copeland, and J. Siddiqui. 2005. Role of interleukin-6 in mortality from and physiologic responses to sepsis. Infect. Immun. 73(5):2751-2757.
24. Kluger, M. J., W. Kozak, L. R. Leon, and C. A. Conn. 1998. The use of knockout mice to understand the role of cytokines in fever. Clin. Exp. Pharmacol. Physiol. 25(2):141-144.
25. Sundgren-Andersson, A. K., P. Ostlund, and T. Bartfai. 1996. IL-6 is essential in TNFα induced fever. Am. J. Physiol. 275:R2028-R2034.
26. Johnston, R. A., I. N. Schwartzman, L. Flynt, and S. A. Shore. 2005. Role of interleukin-6 in murine airway responses to ozone. Am. J. Physiol. Lung Cell Mol. Physiol. 288(2):L390-L397.
27. Akira, S., H. Isshiki, T. Nakajima, S. Kinoshita, Y. Nishio, S. Natsuka, and T. Kishimoto. 1992. Regulation of expression of the interleukin 6 gene: structure and function of the transcription factor NF-IL6. Ciba Found Symp. 167:47-62.
28. Kopf, M., G. Le Gros, A. J. Coyle, M. Kosco-Vilbois, and F. Brombacher. 1995. Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol. Rev. 148:45-69.
29. Tackey, E., P. E. Lipsky, and G. G. Illei. 2004. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus. 13(5):339-343.
30. Choy, E. 2004. Clinical experience with inhibition of interleukin-6. Rheum. Dis. Clin. North Am. 30(2):405-415.
31. Peterson, A. M., and B. K. Pedersen. 2005. The anti-inflammatory effect of exercise. Review. J. Appl. Physiol. 98(4):1154-1162.
32. Gerlai, R., S. P. Williams, B. Cairns, N. Van Bruggen, P. Moran, A. Shih, I. Caras, H. Sauer, H. S. Phillips, and J. W. Winslow. 1998. Protein targeting in the analysis of learning and memory: a potential alternative to gene targeting. Exp. Brain Res. 123(1-2):24-35.
33. Hochgeschwender, U., and M. B. Brennan. 1995. Knock out mice rule OK. Nature 375:543.
34. Gerlai, R. 2001. Gene targeting: technical confounds and potential solutions in behavioral brain research. Behav. Brain Res. 125(1-2):13-21.
35. Routtenberg, A. 1995. Knockout mouse fault lines. Nature 374:314-315.